Return basis
Base
Media/IP base return + contingent upside
Pre-fund marketing information — not an offer.
Pre-fund marketing information — not an offer.
Pre-fund marketing information — not an offer.
A contract-backed film, media and intellectual-property mandate with a base return profile and selective contingent upside after contractual priorities.
Objective: Contract-backed media/IP growth
Access via the applicable Sentry Series, SPV or vehicle under the governing mandate and Product Supplement.
Film, Media & IP
Mandate fit, evidence & economics, legal structure, Investment Committee approval and cash-control readiness.
Verified collections, authorised payments and priority claims, monitored with exception escalation.
Illustrations show a base-basis figure and, where applicable, contingent upside. Gross/net treatment, compounding, timing and tax assumptions are disclosed once approved by Compliance. Figures are indicative and not guaranteed.
Illustrations show a base-basis figure and, where applicable, contingent upside. Gross/net treatment, compounding, timing and tax assumptions are disclosed once approved by Compliance. Figures are indicative and not guaranteed.
Illustrations show a base-basis figure and, where applicable, contingent upside. Gross/net treatment, compounding, timing and tax assumptions are disclosed once approved by Compliance. Figures are indicative and not guaranteed.
Confirmed in the approved Product Supplement.
Effective Annual Cost, gross/net basis and VAT are disclosed on approval; planning assumptions are not published as final.
Fact sheet, Product Supplement and application pack
Provided on request via the Adviser Centre .
24/7 visibility · daily review · active co-control.
Valuation, monitoring and reporting under Investment Committee oversight.
Confirmed in the approved Product Supplement.
Effective Annual Cost, gross/net basis and VAT are disclosed on approval; planning assumptions are not published as final.
Fact sheet, Product Supplement and application pack
Provided on request via the Adviser Centre .
24/7 visibility · daily review · active co-control.
Valuation, monitoring and reporting under Investment Committee oversight.
Confirmed in the approved Product Supplement.
Effective Annual Cost, gross/net basis and VAT are disclosed on approval; planning assumptions are not published as final.
Fact sheet, Product Supplement and application pack
Provided after eligibility review .
24/7 visibility · daily review · active co-control.
Valuation, monitoring and reporting under Investment Committee oversight.
Request the product pack, speak to an adviser, or begin an eligibility review for the restricted route.
Important. Executed legal and transaction documents prevail. Approved Product Supplements and fact sheets control product disclosure. Sentry mandates are high-risk, private and illiquid, intended for qualified investors and licensed advisers only. Website figures are indicative, dated and subject to Compliance approval.